AMER3
ONconsolidatedAMERICANAS S.A. - em Recuperação Judicial
CNPJ 00776574000156
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| JRS CAP PROPRIO | 2021-12-22 | 2022-01-31 | 0.620963 |
| DIVIDENDO | 2011-03-17 | 2011-03-25 | 0.048826 |
| DIVIDENDO | 2011-03-17 | 2011-03-25 | 0.007274 |
| DIVIDENDO | 2010-03-11 | 2010-03-19 | 0.102611 |
| DIVIDENDO | 2009-03-12 | 2009-03-20 | 0.163430 |
| DIVIDENDO | 2008-03-06 | 2008-03-14 | 0.132414 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.31bn | -271.00m | 27.0% | -2.2% | -5.7% | -1.7% | 0.76 | 5.13 | — | — |
| 2024 | 14.35bn | 8.28bn | 32.3% | 57.7% | 166.6% | 47.4% | 0.82 | 6.20 | — | — |
| 2023 | 14.94bn | -2.27bn | 29.2% | -15.2% | — | -8.4% | 0.55 | 0.91 | — | — |
| 2022 | 25.81bn | -12.91bn | 19.5% | -50.0% | — | -41.3% | 0.82 | 9.65 | — | 6.4% |
| 2021 | 22.70bn | 543.80m | 29.8% | 2.4% | 3.4% | 1.2% | 0.51 | 31.58 | 43.52 | — |
| 2020 | 10.12bn | -210.76m | 28.4% | -2.1% | -2.2% | -0.9% | 0.45 | — | — | — |
| 2019 | 6.77bn | -318.24m | 29.7% | -4.7% | -5.6% | -2.0% | 0.42 | — | — | — |
| 2018 | 6.49bn | -397.91m | 25.8% | -6.1% | -11.3% | -3.1% | 0.50 | — | — | — |
| 2017 | 7.12bn | -411.75m | 22.0% | -5.8% | -10.5% | -3.3% | 0.56 | — | — | — |
| 2016 | 8.60bn | -485.90m | 19.9% | -5.7% | -15.8% | -4.7% | 0.84 | — | — | — |
| 2015 | 9.01bn | -418.44m | 19.8% | -4.6% | -15.5% | -4.2% | 0.91 | — | — | — |
| 2014 | 7.96bn | -163.31m | 24.2% | -2.1% | -5.3% | -2.1% | 1.04 | — | — | — |
| 2013 | 6.09bn | -159.56m | 24.8% | -2.6% | -19.2% | -2.4% | 0.92 | — | — | — |
| 2012 | 4.81bn | -170.67m | 23.8% | -3.6% | -17.6% | -3.6% | 1.01 | — | — | — |
| 2011 | 4.23bn | -89.17m | 25.0% | -2.1% | -7.8% | -2.2% | 1.03 | — | — | — |
| 2010 | 4.07bn | 33.59m | 27.9% | 0.8% | 14.9% | 1.1% | 1.27 | — | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 3.30bn | -78.00m | -274.00m | -8.3% |
| Q1 26 | 3.09bn | -203.00m | -329.00m | -10.7% |
| Q4 25 | 3.69bn | 156.00m | -44.00m | -1.2% |
| Q3 25 | 2.69bn | 324.00m | 367.00m | 13.6% |
| Q2 25 | 3.84bn | 82.00m | -98.00m | -2.6% |
| Q1 25 | 3.06bn | -284.00m | -496.00m | -16.2% |
| Q4 24 | 4.37bn | -469.00m | -586.00m | -13.4% |
| Q3 24 | 3.20bn | 279.00m | 10.28bn | 321.5% |
| Q2 24 | 3.11bn | -312.00m | -1.87bn | -59.9% |
| Q1 24 | 3.74bn | 1.15bn | 453.00m | 12.1% |
| Q4 23 | 4.65bn | -1.76bn | 2.34bn | 50.3% |
| Q3 23 | 3.26bn | -646.00m | -1.62bn | -49.7% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 14.55bn | 4.16bn | 3.50 | 1.70 |
| Q1 26 | 16.17bn | 4.43bn | 3.65 | 1.56 |
| Q4 25 | 16.25bn | 4.76bn | 3.41 | 1.67 |
| Q3 25 | 16.15bn | 4.74bn | 3.41 | 1.63 |
| Q2 25 | 16.18bn | 4.38bn | 3.70 | 1.49 |
| Q1 25 | 17.38bn | 4.48bn | 3.88 | 1.49 |
| Q4 24 | 17.47bn | 4.97bn | 3.51 | 1.62 |
| Q3 24 | 18.51bn | 5.72bn | 3.24 | 1.70 |
| Q2 24 | 25.90bn | -30.36bn | — | 0.22 |
| Q1 24 | 26.02bn | -28.51bn | — | 0.22 |
| Q4 23 | 27.12bn | -28.85bn | — | 0.22 |
| Q3 23 | 23.17bn | -31.19bn | — | 0.22 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-12 | 43 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-13 | 43 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-25 | 84 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-12 | 43 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-12 | 43 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-14 | 44 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-26 | 85 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-13 | 44 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-14 | 45 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-08-14 | 136 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-08-14 | 227 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2024-02-26 | 241 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2024-02-26 | 149 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2024-02-26 | 332 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-11-16 | 320 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-10 | 41 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.